Cat.No. |
Nombre químico |
MolFormula |
HR516325 |
Lithium-p-styrenesulfonate |
C8H7LiO3S |
HR498769 |
Loureirin A |
C17H18O4 |
HR498333 |
Lithium triisopropoxy(5-(methoxycarbonyl)pyridin-2-yl)borate |
C16H27BLiNO5 |
HR496132 |
Lithium (3-fluoro-6-methylpyridin-2-yl)trihydroxyborate |
C6H8BFLiNO3 |
HR484921 |
Lithium (2E,4E)-5-bromo-3-methylpenta-2,4-dien-1-olate |
C6H8BrLiO |
HR483990 |
Lauroylcholine Chloride |
C17H36ClNO2 |
HR469942 |
LY2857785 |
C26H36N6O |
HR469902 |
Loreclezole |
C10H6Cl3N3 |
HR469776 |
L189 |
C11H10N4OS |
HR469636 |
Ly451395 |
C21H30N2O4S2 |
HR469605 |
LTV-1 |
C26H20N2O5S |
HR469559 |
Lck Inhibitor |
C31H30N8O |
HR469552 |
Ly2795050 |
C23H22ClN3O2 |
HR469531 |
Ljh685 |
C22H21F2N3O |
HR469443 |
Lometrexol hydrate |
C21H27N5O7 |
HR469294 |
L-Histidinamide, N-[(phenylmethoxy)carbonyl]-L-tryptophyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]methyl ester |
C37H42FN7O10 |
HR469102 |
Ly210073 |
C30H28O8 |
HR469002 |
LY344864 S-Enantiomer |
C21H22FN3O |
HR468908 |
Lp-pla2 -in-1 |
C21H17F5N4O3 |
HR468824 |
Lck inhibitor 2 |
C18H17N5O2 |
HR468760 |
Lecanoricacid |
C16H14O7 |
HR468635 |
LJ570 |
C27H22O3 |
HR468075 |
Liquidambaric lactone |
C30H44O4 |
HR462096 |
Lithium 2-(pyrimidin-4-yl)acetate |
C6H5LiN2O2 |
HR454080 |
Lithium 4-methyl-2-oxo-2H-chromen-7-yl phosphate |
C10H7Li2O6P |
HR453212 |
Lithium 3-fluoropicolinate |
C6H3FLiNO2 |
HR453211 |
Lithium 2-(quinolin-2-yl)acetate |
C11H8LiNO2 |
HR453210 |
Lithium 2-(morpholinomethyl)benzoate |
C12H14LiNO3 |
HR448579 |
Loxoprofen sodium dihydrate |
C15H21NaO5 |
HR447732 |
Lauric Anhydride |
C24H46O3 |